Overview

Decitabine Plus R-CHOP in Diffuse Large B-cell Lymphoma

Status:
Active, not recruiting
Trial end date:
2020-10-01
Target enrollment:
Participant gender:
Summary
This is a Phase I/II Trial of Decitabine + R-CHOP in Diffuse Large B-Cell Lymphoma
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Ruijin Hospital
Treatments:
Azacitidine
Cyclophosphamide
Decitabine
Doxorubicin
Liposomal doxorubicin
Prednisone
Rituximab
Vincristine